Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients

Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients

We aimed to investigate, whether <sup>18</sup>F<i>-</i>2-fluoro-2-desoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) scans performed at baseline (time point 0; TP 0) and three months after initiation of immunotherapy (time point 1; TP 1) can be use...

Full description

Bibliographic Details
Main Authors: Ken Kudura, Florentia Dimitriou, Lucas Basler, Robert Förster, Daniela Mihic-Probst, Tim Kutzker, Reinhard Dummer, Joanna Mangana, Irene A. Burger, Michael C. Kreissl
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
positron emission tomography computed tomography
melanoma
immunotherapy
biomarkers
outcome prediction
Online Access:https://www.mdpi.com/2072-6694/13/15/3830

Internet

https://www.mdpi.com/2072-6694/13/15/3830

Similar Items